Figure 5.

Comparative effects of SLN–DEX and dexamethasone on HEI-OC1 cells’ viability. Cell viability was evaluated by Cell Proliferation Kit II (XTT) assay. HEI-OC1 cells were treated for 24 h (A) or 48 h (B) with different concentrations of dexamethasone (DEX) either alone or combined with SLNs (SLN–DEX) in the absence or presence of 2 or 4 µg/mL cisplatin. Results are shown as mean ± SEM from four independent experiments. The significance of the differences was evaluated using one-way ANOVA testing; ***p < 0.001.